P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference48 articles.
1. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with non metastatic and extremity osteosarcomas;Basaran;Oncology,2007
2. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution;Bacci;J Surg Oncol,2007
3. and Société Française d'Oncologie Pédiatrique (SFOP). SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients;Le Deley;Eur J Cancer,2007
4. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience;Chou;Cancer,2005
5. Modulating MDR: can we target this therapy?;Murren;Clin Cancer Res,2002
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane;Drug Resistance Updates;2024-09
2. Oligomerization of drug transporters: Forms, functions, and mechanisms;Acta Pharmaceutica Sinica B;2024-05
3. Special AT‐rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP‐binding cassette transporters;Cancer Science;2023-01-11
4. Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells;Frontiers in Pharmacology;2022-09-07
5. Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3